Venturi Wealth Management, LLC Fibrogen Inc Transaction History
Venturi Wealth Management, LLC
- $1.96 Billion
- Q3 2025
Shares
1 transactions
Others Institutions Holding FGEN
# of Institutions
7Shares Held
3.98MCall Options Held
35KPut Options Held
0-
Black Rock Inc. New York, NY2.41MShares$20.9 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V81.37MShares$11.9 Million0.0% of portfolio
-
Intercontinental Wealth Advisors, LLC95.7KShares$831,1980.06% of portfolio
-
Eaton Vance Management Boston, MA94.5KShares$821,0130.0% of portfolio
-
Cutler Group LP900Shares$7,8210.0% of portfolio
About FIBROGEN INC
- Ticker FGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,741,200
- Market Cap $815M
- Description
- FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...